ABUJA – The World Health Organization (WHO) has prequalified the R21/Matrix-M malaria vaccine, developed by Oxford University and manufactured by Serum Institute of India, for the prevention of malaria in children.
This marks the second malaria vaccine to receive prequalification from the WHO, following the RTS, S/AS01 vaccine. Both vaccines have demonstrated safety and efficacy in clinical trials.
NigeriaDNA is a Direct News source that delivers the latest news, buzz, and stories from some of Nigeria’s most popular and trusted news websites. NigeriaDNA facilitates this by publishing headlines linking to breaking news and curated snippets from a diverse range of Nigerian credible, independent, and public-interest news sources. Our editors make it easy for Nigerians abroad and diaspora to discover top news stories in real-time as they're posted and directly linked to Nigeria's authoritative News Sources.
© 2024 All Rights Reserved | Curated and Powered by Nigeria DNA
